Estrogen activity as a preventive and therapeutic target in thyroid cancer.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 22285105)

Published in Biomed Pharmacother on December 28, 2011

Authors

Shilpi Rajoria1, Robert Suriano, Andrea L George, Arulkumaran Shanmugam, Casey Jussim, Edward J Shin, Augustine L Moscatello, Jan Geliebter, Angelo Carpi, Raj K Tiwari

Author Affiliations

1: Department of Microbiology and Immunology, New York Medical College, Valhalla, New York 10595, USA.

Articles by these authors

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol (2008) 2.32

Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle (2011) 1.67

Role of genetics in azoospermia. Urology (2010) 1.59

Left ventricular diastolic function and carotid artery wall in elderly athletes and sedentary controls. Biomed Pharmacother (2004) 1.42

Molecular phenotyping of the immune system by microarray analysis. Cancer Invest (2003) 1.38

Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother (2004) 1.30

Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol (2011) 1.29

Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid (2010) 1.28

Use of laboratory evaluation and radiologic imaging in the diagnostic evaluation of children with sensorineural hearing loss. Laryngoscope (2002) 1.25

Comparison of three common tonsillectomy techniques: a prospective randomized, double-blinded clinical study. Laryngoscope (2009) 1.22

Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed) (2011) 1.13

3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem Biophys Res Commun (2005) 1.11

Dedifferentiated thyroid cancer: a therapeutic challenge. Biomed Pharmacother (2008) 1.08

Targeting the immune system in cancer. Curr Pharm Biotechnol (2009) 1.04

Role of 18F-FDG-PET and PET/CT imaging in thyroid cancer. Biomed Pharmacother (2006) 1.01

17Beta-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Res (2008) 1.00

Surface chemistry effects of topographic modification of titanium dental implant surfaces: 1. Surface analysis. Int J Oral Maxillofac Implants (2003) 0.99

Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother (2008) 0.99

Effect of pulsed electromagnetic field stimulation on knee cartilage, subchondral and epyphiseal trabecular bone of aged Dunkin Hartley guinea pigs. Biomed Pharmacother (2007) 0.99

Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. Biomed Pharmacother (2004) 0.98

Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. PLoS One (2011) 0.97

Cardiovascular complications in patients with pheochromocytoma: a mini-review. Biomed Pharmacother (2009) 0.97

Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models. Biomed Pharmacother (2009) 0.97

Testosterone and cardiovascular risk. Intern Emerg Med (2013) 0.97

Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. Laryngoscope (2010) 0.96

Bioactive calcium silicate ceramics and coatings. Biomed Pharmacother (2008) 0.96

Histological substrate of human atrial fibrillation. Biomed Pharmacother (2009) 0.95

Acute effects of hemodialysis on left ventricular function evaluated by tissue Doppler imaging. Biomed Pharmacother (2005) 0.95

Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment. Biomed Pharmacother (2013) 0.94

Biomolecular markers of breast cancer. Front Biosci (2006) 0.93

Thyroidectomy outcomes: a national perspective. Otolaryngol Head Neck Surg (2012) 0.92

Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett (2004) 0.91

Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention. Cancer Res (2005) 0.91

Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases. BMC Cancer (2006) 0.90

Obesity-related glomerulopathy and podocyte injury: a mini review. Front Biosci (Elite Ed) (2012) 0.89

Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother (2005) 0.89

Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS One (2012) 0.88

Neurosurgical implications of allergic fungal sinusitis. J Neurosurg (2004) 0.87

Hemodynamic parameters regulating vascular inflammation and atherosclerosis: a brief update. Biomed Pharmacother (2008) 0.87

Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism (2008) 0.87

Spectral analysis of laser Doppler skin blood flow oscillations in human essential arterial hypertension. Microvasc Res (2006) 0.86

Immune manipulation of advanced breast cancer: an interpretative model of the relationship between immune system and tumor cell biology. Med Res Rev (2009) 0.86

Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis. Prostate (2005) 0.86

Pulmono-atrial shunt and lung assist to treat right ventricular failure. Front Biosci (Landmark Ed) (2011) 0.86

Controlled navigation of endoscopic capsules: concept and preliminary experimental investigations. IEEE Trans Biomed Eng (2007) 0.86

3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways. Oncol Rep (2010) 0.86

Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients. Biomed Pharmacother (2005) 0.85

Estrogen-mediated angiogenesis in thyroid tumor microenvironment is mediated through VEGF signaling pathways. Arch Otolaryngol Head Neck Surg (2011) 0.85

Zones of approach for craniofacial resection: minimizing facial incisions for resection of anterior cranial base and paranasal sinus tumors. Neurosurgery (2003) 0.84

Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma. Laryngoscope (2008) 0.84

DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines. Biomedica (2007) 0.84

Role of obesity , alcohol and smoking on bone health. Front Biosci (Elite Ed) (2012) 0.83

Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions. Glycobiology (2009) 0.83

Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. J Cell Biochem (2012) 0.83

Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Mol Cancer (2012) 0.83

Effect of physical activity on heart rate variability and carotid intima-media thickness in older people. Intern Emerg Med (2013) 0.83

Magnetic shells for gastrointestinal endoscopic capsules as a means to control their motion. Biomed Pharmacother (2006) 0.82

"Tumour marker guided" salvage treatment prolongs survival of breast cancer patients: final report of a 7-year study. Biomed Pharmacother (2003) 0.82

Overexpression of estrogen receptor-α in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology. Cancer Sci (2011) 0.82

Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients. Biomed Pharmacother (2007) 0.82

Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: comparison between oral ferrous bisglycinate chelate and ferrous sulfate. Biomed Pharmacother (2012) 0.82

Minimally invasive radio-guided parathyroidectomy. Biomed Pharmacother (2006) 0.81

Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother (2006) 0.81

Plasma antioxidant activity and cutaneous microvascular endothelial function in athletes and sedentary controls. Biomed Pharmacother (2004) 0.81

Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer. Prostate (2006) 0.81

Skin vasoreactivity to insulin iontophoresis is reduced in elderly subjects and is absent in treated non-insulin-dependent diabetes patients. Biomed Pharmacother (2004) 0.81

3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid (2011) 0.81

Sirtuins: the molecular basis of beneficial effects of physical activity. Intern Emerg Med (2013) 0.81

3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease. Biochem Biophys Res Commun (2005) 0.80

From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules. Biomed Pharmacother (2004) 0.80

Utility of a serum tumour marker panel in the post-operative follow-up of breast cancer patients with equivocal conventional radiological examinations. Tumour Biol (2004) 0.80

Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity. Biomed Pharmacother (2005) 0.80

Presence of a functional TSH receptor on human erythrocytes. Biomed Pharmacother (2007) 0.80

Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides (2004) 0.80

Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines. J Cancer (2013) 0.80